Dolph Lundgren is opening up about his ongoing cancer battle.
The “Rocky” actor revealed that he was told that he only had “two or three years” left to live in 2021 after kidney cancer spread. Lundgren was in London at the time Production Begins on “Aquaman and the Lost Kingdom” and “The Expendables 4.”
more from indiewire
“We realized it was a lot worse than we thought,” Lundgren said during the latest “In Depth with Graham Bensinger” interview (below). ,[The doctor] Kind of started talking about all these different tumors, like, in the lungs and abdomen and spinal cord, outside the kidneys. He started saying things like, ‘You should probably take a break and spend more time with your family,' and so on.
Lundgren continued, “I asked him, ‘How long do you think I have left?' I think he said two or three years, but I could tell in his voice that he probably thought it was less.
The actor's cancer was first detected in 2015 when a tumor was removed.
“Then I did scans every six months, then you do it every year and it was fine, you know, for five years,” Lundgren said. “In 2020, I was back in Sweden and I had some kind of acid reflux or… I didn't know what it was. So I did an MRI and they found that there were a few more tumors around the area.
Six more tumors were discovered by doctors, which led Lundgren to introduce systemic therapy and treatment, which reflects how lung cancer is controlled.
“If I had gone on another treatment, I would have had about three to four months left,” Lundgren said, adding that the lung cancer treatment is shrinking his tumor by about 30 percent within a three-month period.
“2022 was basically seeing these drugs doing their job,” summed up Lundgren. “Eventually things had shrunk down to about 90 per cent. Now I'm in the process of taking out the remaining scar tissue in those tumors… The prognosis is that, hopefully, when they take them out, there will be no cancer activity and the medication I'm taking will suppress everything else. Will give ,
best of indiewire
sign up for IndieWire's newsletter, Follow us for latest news Facebook, TwitterAnd Instagram,